Results 81 to 90 of about 13,334 (226)
Reducing cholinergic constriction: the major reversible mechanism in COPD
European Respiratory Review, 2006 The airway narrowing in chronic obstructive pulmonary disease (COPD) has often been misunderstood as being irreversible. However, a large proportion of patients with COPD do respond to bronchodilator agents with significant changes in lung function ...
V. Brusasco
doaj
Outpatient utilization trend of bronchodilator and anti-inflammatory agents in the pandemic and beyond [PDF]
Neriman İpek Kırmızı +4 more
openalex +1 more source
Methacholine challenge testing: comparative pharmacology
Journal of Asthma and Allergy, 2018 Beth E Davis, Christianne M Blais, Donald W Cockcroft Division of Respirology, Critical Care and Sleep Medicine, Department of Medicine, University of Saskatchewan, Saskatoon, SK, Canada Abstract: Standardization of the methacholine inhalation challenge,
Davis BE, Blais CM, Cockcroft DW
doaj
Pharmacodynamics of a bronchodilator agent DO-309 in its repetitive admimistration test.
, 1994 Eiji Uchida
openalex +2 more sources
Effects of bronchospastic and bronchodilator agents on guinea pig trachobronchial smooth muscle
, 1976 Christopher J. Hanna
openalex +1 more source
International Journal of COPD, 2017 Keisaku Fujimoto,1 Haruna Yamazaki,2 Midori Ura,2 Yoshiaki Kitaguchi3 1Department of Clinical Laboratory Sciences, School of Health Sciences, 2Department of Biomedical Laboratory Science, Graduate School of Medicine, 3First Department of Internal ...
Fujimoto K +3 more
doaj